Serologic response to primary vaccination with 7-valent pneumococcal conjugate vaccine is better than with 23-valent pneumococcal polysaccharide vaccine in HIV-infected patients in the era of combination antiretroviral therapy

Objectives: The objectives of this study were to compare the serologic responses at week 48 to primary vaccination with 23-valent pneumococcal polysaccharide vaccine (PPV) vs. 7-valent pneumococcal conjugate vaccine (PCV); and to identify factors associated with serologic response in HIV-infected ad...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Lu, Ching-Lan, Hung, Chien-Ching, Chuang, Yu-Chung, Liu, Wen-Chun, Su, Chin-Ting, Su, Yi-Ching, Chang, Shu-Fang, Chang, Sui-Yuan, Chang, Shan-Chwen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Landes Bioscience 2013
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3859763/
https://ncbi.nlm.nih.gov/pubmed/23291936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.22836
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia